 PLYMOUTH MEETING, Pa. and CHICAGO, Nov. 11, 2020 PRNewswire -- Harmony Biosciences Holdings, Inc. Harmony Nasdaq: HRMY, a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients living with rare neurological disorders who have unmet... 